Baltic and Eurasia Masterclass in Clinical Oncology
The Role of Targeted and Chemotherapy in Metastatic NSCLC: TKIs in EGFRm, Mechanisms of Acquired Resistance, and New Treatment Options
Comments 0
Login to view comments.
Click here to Login
